Search research articles
Contact Us
Filters
Showing results (101-110 of 112) with videos related to
Page
of 12
Sort By:
European Urology
|
February 27, 2025
Effects of Enzalutamide on the Sexual Activity of Patients with Biochemically Recurrent Prostate Cancer: A Post Hoc Analysis of Patient-reported Outcomes in the EMBARK Study
Stephen J Freedland, John P Mulhall, Martin Gleave, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 11, 2024
Dose-Dense Mini-Hyper-CVD, Inotuzumab Ozogamicin and Blinatumomab Achieves Rapid MRD-Negativity in Philadelphia Chromosome-Negative B-cell Acute Lymphoblastic Leukemia
Nicholas J Short, Elias Jabbour, Trevor Jamison, et al.
Cancers
|
May 11, 2024
High-Grade Pleomorphic Sarcomas Treated with Immune Checkpoint Blockade: The MD Anderson Cancer Center Experience
Lewis F Nasr, Marianne Zoghbi, Rossana Lazcano, et al.
Frontiers in Oncology
|
September 26, 2024
Outcomes and toxicities in patients with diffuse-large B cell lymphoma involving the gastrointestinal tract and digestive organs
Gohar S Manzar, Elaine E Cha, Kelsey L Corrigan, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 21, 2024
Outcome of Patients With Central Nervous System Multiple Myeloma (CNS-MM) Treated With CNS-Directed Radiation Therapy
Gohar S Manzar, Stephanie O Dudzinski, Alison K Yoder, et al.
Blood
|
March 29, 2024
Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL
Yaqi Zhao, Nicholas J Short, Hagop M Kantarjian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 26, 2024
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory <i>FLT3</i>-Mutated AML
Nicholas J Short, Naval Daver, Courtney D Dinardo, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 18, 2023
Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL
Yaqi Zhao, Nicholas J Short, Hagop M Kantarjian, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 20, 2024
Characterization of Lymphopenia and Correlating the Risk of Cytopenias With Dose and Bone Marrow Volume Irradiated in Aggressive B Cell Lymphoma Patients Bridged With Radiation Therapy for Chimeric Antigen Receptor-T Cell Therapy
Gohar S Manzar, Susan Y Wu, Stephanie O Dudzinski, et al.
Frontiers in Immunology
|
February 17, 2025
Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomas
Gohar S Manzar, Chelsea C Pinnix, Stephanie O Dudzinski, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 112) with videos related to
Sort By:
Page
of 12
European Urology
|
February 27, 2025
Effects of Enzalutamide on the Sexual Activity of Patients with Biochemically Recurrent Prostate Cancer: A Post Hoc Analysis of Patient-reported Outcomes in the EMBARK Study
Stephen J Freedland, John P Mulhall, Martin Gleave, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 11, 2024
Dose-Dense Mini-Hyper-CVD, Inotuzumab Ozogamicin and Blinatumomab Achieves Rapid MRD-Negativity in Philadelphia Chromosome-Negative B-cell Acute Lymphoblastic Leukemia
Nicholas J Short, Elias Jabbour, Trevor Jamison, et al.
Cancers
|
May 11, 2024
High-Grade Pleomorphic Sarcomas Treated with Immune Checkpoint Blockade: The MD Anderson Cancer Center Experience
Lewis F Nasr, Marianne Zoghbi, Rossana Lazcano, et al.
Frontiers in Oncology
|
September 26, 2024
Outcomes and toxicities in patients with diffuse-large B cell lymphoma involving the gastrointestinal tract and digestive organs
Gohar S Manzar, Elaine E Cha, Kelsey L Corrigan, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 21, 2024
Outcome of Patients With Central Nervous System Multiple Myeloma (CNS-MM) Treated With CNS-Directed Radiation Therapy
Gohar S Manzar, Stephanie O Dudzinski, Alison K Yoder, et al.
Blood
|
March 29, 2024
Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL
Yaqi Zhao, Nicholas J Short, Hagop M Kantarjian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 26, 2024
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory <i>FLT3</i>-Mutated AML
Nicholas J Short, Naval Daver, Courtney D Dinardo, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 18, 2023
Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL
Yaqi Zhao, Nicholas J Short, Hagop M Kantarjian, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 20, 2024
Characterization of Lymphopenia and Correlating the Risk of Cytopenias With Dose and Bone Marrow Volume Irradiated in Aggressive B Cell Lymphoma Patients Bridged With Radiation Therapy for Chimeric Antigen Receptor-T Cell Therapy
Gohar S Manzar, Susan Y Wu, Stephanie O Dudzinski, et al.
Frontiers in Immunology
|
February 17, 2025
Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomas
Gohar S Manzar, Chelsea C Pinnix, Stephanie O Dudzinski, et al.
Page
of 12